Clinical Trials in France / NCT05978362
Recruiting
Not applicable
Value of Capsular Repair for Latarjet
NCT05978362 · tracked via the Priya Life Science France tracker
Condition(s) studied
Shoulder Pain
Investigational drug(s) / intervention(s)
Latarjet technique
Latarjet technique: Realization of a stop according to Latarjet
Study summary
The purpose of the study is to evaluate the occurrence of osteoarthritis (YES/NO) by radiography.
Eligibility
Inclusion Criteria:
* Patient, male or female, over the age of 18
* Patient with shoulder instability with risk factors for recurrence (ISIS score \> 3), requiring surgical stabilization by abutment
* Affiliated patient or beneficiary of a social security scheme
* Patient having been informed and having given his free, informed and written consent.
Exclusion Criteria:
* Patient with history of surgery for instability of the same shoulder
* Patient presenting contraindications to the realization of a postoperative scanner
* Patient whose physical and/or psychological health is severely impaired, which according to the investigator may affect the compliance of the study participant
* Patient participating in another clinical research or in a period of exclusion from another research still in progress at the time of inclusion
* Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
* Pregnant, breastfeeding or parturient woman
* Patient hospitalized without consent.
Primary outcome measure(s)
- occurrence of osteoarthritis — 10 years
Change from occurrence of osteoarthritis (YES/NO) on X-ray at 5 and 10 years, compared to inclusion X-ray using the Samilson-Prieto classification.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Clinique Maussins-Nollet | Paris | France | Recruiting |
More GCS Ramsay Santé pour l'Enseignement et la Recherche trials in France
ENDOmetriosis Robotic Assisted Surgery
Recruiting
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05978362 on ClinicalTrials.gov ↗ ← All trials in France